Jinxin Fertility Group Ltd
HKEX:1951

Watchlist Manager
Jinxin Fertility Group Ltd Logo
Jinxin Fertility Group Ltd
HKEX:1951
Watchlist
Price: 2.94 HKD -6.37% Market Closed
Market Cap: 8.1B HKD
Have any thoughts about
Jinxin Fertility Group Ltd?
Write Note

Jinxin Fertility Group Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinxin Fertility Group Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Jinxin Fertility Group Ltd
HKEX:1951
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Other Liabilities
ÂĄ23.9m
CAGR 3-Years
-16%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Other Liabilities
ÂĄ15.1m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Other Liabilities
ÂĄ159m
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
23%
Dian Diagnostics Group Co Ltd
SZSE:300244
Other Liabilities
ÂĄ526.7m
CAGR 3-Years
96%
CAGR 5-Years
15%
CAGR 10-Years
54%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Other Liabilities
ÂĄ21.6m
CAGR 3-Years
11%
CAGR 5-Years
-29%
CAGR 10-Years
2%
No Stocks Found

Jinxin Fertility Group Ltd
Glance View

Market Cap
8.1B HKD
Industry
Health Care

Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.

Intrinsic Value
4.77 HKD
Undervaluation 38%
Intrinsic Value
Price

See Also

Back to Top